As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of HIV research findings at the International ...

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

Researchers remain hopeful that they're heading in the right direction to finding a cure for HIV, the virus that causes AIDS. Right now, it’s still out of reach. But the unusual cases of four ...

Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need ...

A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...

Nebraska Aids Project is celebrating 40 years with its annual Night of a Thousand Stars fundraiser. The gala will contribute ...

Our HIV epidemic is one of the fastest growing in the world. While there have been many improvements in access to care and life-saving treatment, it cannot be business as usual since more and more ...

While a cure sounds like great news ... driven by slower growth in the HIV franchise. The company posted adjusted earnings of ...

Identifying best practices that will prevent HCV transmission in MSM with HIV is needed to reduce HCV reinfection rates in ...

Professor Thumbi Ndung’u from UKZN has been elected to the US National Academy of Medicine, recognising his significant contributions to HIV research ...

Immunocore reports third quarter financial results and provides a business updateKIMMTRAK® (tebentafusp-tebn) net revenues of $80.2 million in 3Q ...